Skyline Venture Management IV, LLC
Insider CIK 1392103 · PRTO 10% owner · CNCE 10% owner · TTPH 10% owner · ACRX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,173,913 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,341,664 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 5,000,000 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 2,436,437 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 3,932,747 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-29 | 1,389,064 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise deriv | 2014-10-27 | 2014-10-29 | 121,760 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 200,000 | $10.00 | $2.00M | 200,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 1,167,208 | — | $0 | 1,367,208 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | X Exercise | 2014-10-27 | 2014-10-29 | 121,760 | $4.60 | $560.1K | 1,488,968 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | S Sale | 2014-10-27 | 2014-10-29 | 56,038 | $10.00 | $560.4K | 1,432,930 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 4,493 | — | $0 | 4,493 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 300,000 | — | $0 | 1,890,146 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2014-03-07 | 2014-03-11 | 1,300,000 | — | $0 | 2,871,933 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 2,200,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-20 | 2014-02-21 | 600,000 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-20 | 2014-02-21 | 150,000 | $14.00 | $2.10M | 1,208,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 106,194 | — | $0 | 1,058,920 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 530,974 | — | $0 | 952,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-20 | 2014-02-21 | 389,380 | — | $0 | 421,752 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 27,226,760 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,090,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,726,086 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 11,422,045 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 393,863 | — | $0 | 570,280 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 938,853 | — | $0 | 1,509,133 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 681,012 | $7.00 | $4.77M | 2,190,145 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 94,003 | — | $0 | 176,417 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 72,069 | — | $0 | 82,414 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 256,228 | $0.13 | $33.3K | 256,228 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 284,698 | $3.40 | $968.0K | 4,161,933 | SEC↗ |